Division of Cardiovascular and Medical Sciences, Epilepsy Unit, Western Infirmary, Glasgow G11 6NT, Scotland, UK.
Division of Cardiovascular and Medical Sciences, Epilepsy Unit, Western Infirmary, Glasgow G11 6NT, Scotland, UK.
Neurol Clin. 2009 Nov;27(4):967-992. doi: 10.1016/j.ncl.2009.06.007.
Epilepsy affects approximately 50 million people worldwide, with an annual incidence of 50 to 70 cases per 100,000 population. The condition can strike at any time of life, with an immediate impact on everyday activities and routine. Key to optimal management is swift referral to an epilepsy specialist, appropriate investigation, and timely institution of antiepileptic drug therapy. In the past 20 years, the explosion of 13 new agents into the marketplace has greatly increased the potential for therapeutic intervention. This article explores the rationale for treatment selection in adults with epilepsy.
癫痫影响全球约 5000 万人，每年每 10 万人中有 50 至 70 例新发病例。这种情况可能在任何年龄段发作，直接影响日常活动和日常生活。最佳管理的关键是迅速转介给癫痫专家，进行适当的检查，并及时开始抗癫痫药物治疗。在过去的 20 年中，市场上出现了 13 种新药物，大大增加了治疗干预的可能性。本文探讨了成人癫痫治疗选择的原理。
